相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer
Prahlad V. Raninga et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula Gonzalez-Ericsson et al.
JOURNAL OF PATHOLOGY (2020)
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression
Thomas J. Rogers et al.
MOLECULAR CANCER RESEARCH (2019)
Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
Thomas Treiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation
Zuo-Lin Li et al.
KIDNEY INTERNATIONAL (2019)
Nanoparticle Delivery of miR-708 Mimetic Impairs Breast Cancer Metastasis
Divya Ramchandani et al.
MOLECULAR CANCER THERAPEUTICS (2019)
The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma
Xue Bai et al.
PLOS ONE (2019)
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
Gloria V. Echeverria et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
Qian Tang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Targeted Therapies for Triple-Negative Breast Cancer
Tomas G. Lyons
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
Laura Cantini et al.
NUCLEIC ACIDS RESEARCH (2019)
1 A Systematic Review of miR-29 in Cancer
Jason J. Kwon et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
Dong-Yu Wang et al.
BREAST CANCER RESEARCH (2019)
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
Eduardo Tormo et al.
SCIENTIFIC REPORTS (2019)
Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity
Junling Liu et al.
JOURNAL OF PATHOLOGY (2018)
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions
Chih-Hung Chou et al.
NUCLEIC ACIDS RESEARCH (2018)
Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer
Javad Razaviyan et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2018)
LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1
Jianli Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MicroRNAs as novel biomarkers for colorectal cancer: New outlooks
Naghmeh Shirafkan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007
Naoise C. Synnott et al.
CANCER LETTERS (2018)
Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer sternness and metastasis by inhibiting the Src/Vav2/Rac1 pathway
Yajuan Xiao et al.
CANCER LETTERS (2018)
Emerging therapeutic modalities of PARP inhibitors in breast cancer
Xin Wang et al.
CANCER TREATMENT REVIEWS (2018)
Breast Cancer and Ovulation Induction Treatments
Robabeh Taheripanah et al.
CLINICAL BREAST CANCER (2018)
Novel prognostic and predictive microRNA targets for triple-negative breast cancer
Gulisa Turashvili et al.
FASEB JOURNAL (2018)
Neuroprotection afforded by circadian regulation of intracellular glutathione levels: A key role for miRNAs
Chisato Kinoshita et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
Janaki Ramaiah Mekala et al.
GENE (2018)
MicroRNAs in regulation of triple-negative breast cancer progression
Dominika Piasecka et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Role of miR-203 in estrogen receptor-mediated signaling in the rat uterus and endometrial carcinoma
Oliver Zierau et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Circular RNA and its mechanisms in disease: From the bench to the clinic
Bing Han et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Angiogenic role of miR-20a in breast cancer
Gines Luengo-Gil et al.
PLOS ONE (2018)
MicroRNA-10b expression in breast cancer and its clinical association
Jianhui Zhang et al.
PLOS ONE (2018)
MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
Yaming Li et al.
CELL DEATH & DISEASE (2018)
The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b
Khalid Sossey-Alaoui et al.
SCIENTIFIC REPORTS (2018)
Increased expression of miR-155 and miR-222 is associated with lymph node positive status
Vladimir Chernyy et al.
JOURNAL OF CANCER (2018)
Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection
Vrantika Chaudhary et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Notch, BMP and WNT/β-catenin network is impaired in endothelial cells of the patients with thoracic aortic aneurysm
Aleksandra Kostina et al.
ATHEROSCLEROSIS SUPPLEMENTS (2018)
Epigenetics and Epi-miRNAs: Potential markers/therapeutics in leukemia
Fatemeh Memari et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
Patricia Midori Murobushi Ozawa et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Genetic Markers in Triple-Negative Breast Cancer
Zuzana Sporikova et al.
CLINICAL BREAST CANCER (2018)
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
Mihriban Karaayvaz et al.
NATURE COMMUNICATIONS (2018)
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
Mustafa Kahraman et al.
SCIENTIFIC REPORTS (2018)
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
Simona D'Aguanno et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
Gaofeng Xiong et al.
NATURE COMMUNICATIONS (2018)
Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort
Homero Goncalves et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2018)
MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer
M. Xiao et al.
BRITISH JOURNAL OF SURGERY (2018)
Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer
Jason. P. W. Carey et al.
CANCER RESEARCH (2018)
BCL2 and miR-15/16: from gene discovery to treatment
Yuri Pekarsky et al.
CELL DEATH AND DIFFERENTIATION (2018)
miR-221/222 activate the Wnt/beta-catenin signaling to promote triple-negative breast cancer
Sanhong Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2018)
PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
Jill J. J. Geenen et al.
CLINICAL PHARMACOKINETICS (2018)
Epigenetic Silencing of miR-200c in Breast Cancer Is Associated With Aggressiveness and Is Modulated by ZEB1
Valentina Damiano et al.
GENES CHROMOSOMES & CANCER (2017)
RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis
Feifei Chen et al.
ONCOTARGET (2017)
Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer
Min Hye Jang et al.
HUMAN PATHOLOGY (2017)
The role of exosomes and miRNAs in drug-resistance of cancer cells
Duc-Hiep Bach et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
miR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha
Li-Li Liu et al.
MOLECULAR MEDICINE (2017)
Integrated analysis of the potential roles of miRNA-mRNA networks in triple negative breast cancer
Huiru Zhu et al.
MOLECULAR MEDICINE REPORTS (2017)
LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism
Gangqiang Ding et al.
ONCOTARGETS AND THERAPY (2017)
miR-200b inhibits CD133+ glioma cells by targeting the AKT pathway
Aiqun Liu et al.
ONCOLOGY LETTERS (2017)
Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation
Rosa Drago-Ferrante et al.
ONCOTARGET (2017)
miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans
Q. Zheng et al.
ONCOGENESIS (2017)
Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment
Emma Bell et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2017)
Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis
Jacek M. Kwiecien et al.
PLOS ONE (2017)
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
Hao-Yi Li et al.
BREAST CANCER RESEARCH (2017)
The Dual Regulatory Role of MiR-181a in Breast Cancer
Chun Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
Sunyoung Park et al.
BMC CANCER (2017)
Tamoxifen reverses epithelial mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
Qian Wang et al.
BMC CANCER (2017)
MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer
J. Yu et al.
NEOPLASMA (2017)
The Role of Angiogenesis in Cancer Treatment
Mehdi Rajabi et al.
BIOMEDICINES (2017)
Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial mesenchymal transition (EMT)
Qiong Pan et al.
CANCER LETTERS (2017)
Toxicity evaluation of magnetic hyperthermia induced by remote actuation of magnetic nanoparticles in 3D micrometastasic tumor tissue analogs for triple negative breast cancer
Nathanael A. Stocke et al.
BIOMATERIALS (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
Brian D. Adams et al.
CANCER RESEARCH (2016)
Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development
Chuan Jin et al.
TUMOR BIOLOGY (2016)
Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer
Zhongxing Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer
Jiawei Chen et al.
BMC CANCER (2016)
Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer
Yongwen Li et al.
CANCER BIOLOGY & THERAPY (2016)
MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer
L. Tang et al.
CANCER GENE THERAPY (2016)
New Insights Into miR-17-92 Cluster Regulation and Angiogenesis
Jan Fiedler et al.
CIRCULATION RESEARCH (2016)
MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer
Long-ji Luo et al.
GENE (2016)
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Caterina Catalanotto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1
Sukanya Shyamasundar et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer
Lei Huo et al.
MODERN PATHOLOGY (2016)
The tumour hypoxia induced non-coding transcriptome
Hani Choudhry et al.
MOLECULAR ASPECTS OF MEDICINE (2016)
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
S. Baroni et al.
CELL DEATH & DISEASE (2016)
A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
Le Qu et al.
NATURE COMMUNICATIONS (2016)
Inhibition of miR-21 by 3′/5′-Serinyl-Capped 2′-O-Methyl RNA Interspersed with 2′-O-(2-Amino-3-Methoxypropyl) Uridine Units
Smita Nahar et al.
NUCLEIC ACID THERAPEUTICS (2016)
High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
Zhi-Gang Cao et al.
ONCOTARGET (2016)
miR-182 Regulates Metabolic Homeostasis by Modulating Glucose Utilization in Muscle
Duo Zhang et al.
CELL REPORTS (2016)
Effects of mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)/Vascular Endothelial Growth Factor (VEGF) Signal Pathway
Feng Yang et al.
MEDICAL SCIENCE MONITOR (2016)
microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection
Rimi Hamam et al.
SCIENTIFIC REPORTS (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes
Yan Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Role of epithelial-mesenchymal transition markers in triple-negative breast cancer
Sai Yin Cheung et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer
Peng Liu et al.
CANCER LETTERS (2015)
miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene
Efrosini Tsouko et al.
CARCINOGENESIS (2015)
Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
Min Hye Jang et al.
HUMAN PATHOLOGY (2015)
miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
Andrea Mathe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Diverse functions of miR-373 in cancer
Furong Wei et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
Yujie Zhao et al.
ONCOLOGIST (2015)
MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer
De Chen et al.
ONCOTARGET (2015)
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
Leticia De Mattos-Arruda et al.
ONCOTARGET (2015)
A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
Kristine Kleivi Sahlberg et al.
CLINICAL CANCER RESEARCH (2015)
lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Gabriel Eades et al.
MOLECULAR CANCER RESEARCH (2015)
MicroRNA-21 Regulates PI3K/Akt/mTOR Signaling by Targeting TGFβI during Muscle Development in Pigs
Lijing Bai et al.
PLOS ONE (2015)
IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer
Biao Dong et al.
PLOS ONE (2015)
MicroRNA expression profiles of serum from patients before and after chemotherapy
Yvonne Diener et al.
GENOMICS DATA (2015)
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
Tomohiro Umezu et al.
BLOOD (2014)
The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17∼92 cluster
Lianjin Jin et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer
Xu Han et al.
CANCER GENE THERAPY (2014)
MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
Brock Humphries et al.
CARCINOGENESIS (2014)
MicroRNA control of epithelial-mesenchymal transition in cancer stem cells
Jin Hao et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice
Hiroto Hatakeyama et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
S. Ramakrishnan et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2014)
MicroRNA-542-3p inhibits tumour angiogenesis by targeting Angiopoietin-2
Ting He et al.
JOURNAL OF PATHOLOGY (2014)
microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells
Yi Ren et al.
MOLECULAR MEDICINE REPORTS (2014)
miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer
Jun Wang et al.
MOLECULAR ONCOLOGY (2014)
MiR-148a-and miR-216a-regulated Oncolytic Adenoviruses Targeting Pancreatic Tumors Attenuate Tissue Damage Without Perturbation of miRNA Activity
Xavier Bofill-De Ros et al.
MOLECULAR THERAPY (2014)
MiR-155 at the heart of oncogenic pathways
M. F. Czyzyk-Krzeska et al.
ONCOGENE (2014)
A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
Songjie Shen et al.
PLOS ONE (2014)
MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
Imen Medimegh et al.
PLOS ONE (2014)
miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
C. Denoyelle et al.
CELL DEATH & DISEASE (2014)
Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis
D. Zhang et al.
CELL DEATH & DISEASE (2014)
MiR-9 promotes microglial activation by targeting MCPIP1
Honghong Yao et al.
NATURE COMMUNICATIONS (2014)
MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
Ye Song et al.
ONCOTARGET (2014)
miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer
Xiaohui Tan et al.
BREAST CANCER RESEARCH (2014)
Hypoxia-regulated microRNAs in human cancer
Guomin Shen et al.
ACTA PHARMACOLOGICA SINICA (2013)
Connect the dots A systems level approach for analyzing the miRNA-mediated cell death network
Yifei Li et al.
AUTOPHAGY (2013)
Oncogenic miR-181a/b afect the DNA damage response in aggressive breast cancer
Andrea Bisso et al.
CELL CYCLE (2013)
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
E. Mogilyansky et al.
CELL DEATH AND DIFFERENTIATION (2013)
Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
Corinna Eichelser et al.
CLINICAL CHEMISTRY (2013)
Regulation of Breast Cancer and Bone Metastasis by MicroRNAs
S. Vimalraj et al.
DISEASE MARKERS (2013)
MicroRNAs and Triple Negative Breast Cancer
Elvira D'Ippolito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review)
Roberta Piva et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
TGF-beta upregulates miR-181a expression to promote breast cancer metastasis
Molly A. Taylor et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Genomic and Epigenomic Cross-talks in the Regulatory Landscape of miRNAs in Breast Cancer
Devyani Samantarrai et al.
MOLECULAR CANCER RESEARCH (2013)
MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer
J. Johansson et al.
ONCOGENE (2013)
Targeted Ablation of miR-21 Decreases Murine Eosinophil Progenitor Cell Growth
Thomas X. Lu et al.
PLOS ONE (2013)
被撤回的出版物: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells (Retracted article. See vol. 12, art no e0175869, 2017)
Rounak Nassirpour et al.
PLOS ONE (2013)
miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
Kinya Okamoto et al.
PLOS ONE (2013)
Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis
Shuet Theng Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
miR-139-5p is a regulator of metastatic pathways in breast cancer
Keerthana Krishnan et al.
RNA (2013)
Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1
Hailing Liu et al.
TUMOR BIOLOGY (2013)
Epigenetic Regulation of Cancer Stem Cell Genes in Triple-Negative Breast Cancer
Naofumi Kagara et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
Chen Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer
Katarzyna Augoff et al.
MOLECULAR CANCER (2012)
Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells
Aamir Ahmad et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
Claudia Piovan et al.
MOLECULAR ONCOLOGY (2012)
Comparing the MicroRNA Spectrum between Serum and Plasma
Kai Wang et al.
PLOS ONE (2012)
miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer
Erin N. Howe et al.
PLOS ONE (2012)
MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression
Bing Qin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer
H. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2011)
MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features
Juan Xu et al.
NUCLEIC ACIDS RESEARCH (2011)
MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer
Cathy A. Andorfer et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
Ana Bosch et al.
CANCER TREATMENT REVIEWS (2010)
MicroRNA: Biogenesis, Function and Role in Cancer
Leigh-Ann MacFarlane et al.
CURRENT GENOMICS (2010)
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma
Liqiang Qi et al.
BMC CANCER (2009)
Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
Douglas R. Hurst et al.
CANCER RESEARCH (2009)
Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis
Yujie Huang et al.
CANCER RESEARCH (2009)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Association of polymorphisms of angiogenesis genes with breast cancer
Bryan P. Schneider et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
